Healthcare Industry News: radiosurgery
News Release - September 29, 2015
Elekta States That Varian Claims Lack MeritSTOCKHOLM--(Healthcare Sales & Marketing Network)--Varian Medical Systems filed civil lawsuits and made a request that the United States International Trade Commission (USITC) initiate a patent infringement proceeding against Elekta on September 25, 2015. Elekta states that the claims have no merit and will defend itself vigorously.
Elekta president and CEO Tomas Puusepp said: “We do not foresee any material business impact as a result of these claims. They are apparently part of Varian’s legal strategy against a lawsuit from William Beaumont Hospital and Elekta Ltd. earlier this year.”
On June 16, 2015, William Beaumont Hospital and Elekta Ltd. filed a patent infringement suit against Varian Medical Systems, Inc. in the United States District Court for the Eastern District of Michigan. The patents in suit are owned by William Beaumont Hospital and exclusively licensed to Elekta Ltd. The suit charges that Varian's True Beam linear accelerator infringes the patents.
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 08:30 CET on September 29, 2015.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.